adipose-derived adult stem cell therapy (Zen-Bio)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameadipose-derived adult stem cell therapy (Zen-Bio)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Pancreagenic potential stem cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Adipose stem cell therapy

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesZen-Bio Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesZen-Bio Inc

Active IndicationsN/A

Inactive IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1

Other Information

ATC CodeN/A